Clinical status of follicular dendritic cell sarcoma
CHEN Dinglang1 JING Renyi2 CHEN Dingzhi1 SU Zhixiong3▲
1. Department of General Practice, the Second Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning 530007, China;
2. Graduate School of Clinical Medicine, Shihezi University, Xinjiang Uygur Autonomous Region, Shihezi 832003, China;
3. Department of General Surgery, Wuming Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning 530019, China
Abstract：Follicular dendritic cell sarcoma (FDCS), as a clinically visible malignant tumor, has not yet formed a unified description of its pathogenesis, clinical manifestations, diagnosis and treatment, which leads to its easy misdiagnosis and delayed diagnosis. Due to the different location of the disease, many patients often have different symptoms such as slow-growing painless mass, abdominal manifestations including abdominal pain, abdominal distension and abdominal mass, and constitutional symptoms. If not diagnosed as soon as possible and scientific treatment measures are taken,the physical and mental health of patients will be seriously affected.In the existing diagnosis and treatment records of FDCS, surgery is basically the main means to control the patients′ condition. Therefore, this paper analyzes the current clinical situation of FDCS from the perspective of review and tries to describe the related etiology and pathogenesis, clinical manifestations, imaging features, pathological features, differential diagnosis, treatment, and prognosis of FDCS, to deepen our understanding of FDCS and provide a new perspective for future research on its pathogenesis.
Monda L，Warnke R，Rosai J.A primary lymph node malignancy with features suggestive of dendritic reticulum cell differentiation. A report of 4 cases[J].Am J Pathol，1986，122（3）：562-572.
[3]
Chan JK，Tsang WY，Ng CS，et al.Follicular dendritic cell tumors of the oral cavity[J].Am J Surg Pathol，1994，18（2）：148-157.
[4]
Campo E，Swerdlow SH，Harris NL，et al.The 2008 WHO classification of lymphoid neoplasms and beyond：evolving concepts and practical applications[J].Blood，2011，117（19）：5019-5032.
[5]
Facchetti F，Pileri SA，Lorenzi L，et al.Histiocytic and dendritic cell neoplasms：what have we learnt by studying 67 cases[J].Virchows Arch，2017，471（4）：467-489.
[6]
Viola P，Vroobel KM，Devaraj A，et al.Follicular dendritic cell tumour/sarcoma：a commonl y misdiagnosed tumour in the thorax[J].Histopathology，2016，69（5）：752-761.
Sun X，Chang KC，Abruzzo LV，et al.Epidermal growth factor receptor expression in follicular dendritic cells：a shared feature of follicular dendritic cell sarcoma and Castleman′s disease[J].Hum Pathol，2003，34（9）：835-840.
[9]
Chan AC，Chan KW，Chan JK，et al.Development of follicular dendritic cell sarcoma in hyaline-vascular Castleman′s disease of the nasopharynx: tracing its evolution by sequential biopsies[J].Histopathology，2001，38（6）：510-518.
Saygin C，Uzunaslan D，Ozguroglu M，et al.Dendritic cell sarcoma：a pooled analysis including 462 cases with presentation of our case series[J].Crit Rev Oncol Hematol，2013，88（2）：253-271.
Sander B，Middel P，Gunawan B，et al.Follicular dendritic cell sarcoma of the spleen[J].Hum Pathol，2007，38（4）：668-672.
[15]
Chin KM，Ho WY，Lim KHT，et al.Follicular dendritic cell sarcoma of the liver with metachronous small bowel and splenic metastases：a case report and literature review[J].Hepatobiliary Surg Nutr，2017，6（3）：179-189.
Bouriga R，Abdessaied N，Hochlef M，et al.Retroperitoneal follicular dendritic cell sarcoma in a young woman：Diagnosis and treatment challenges[J].Curr Probl Cancer，2018，42（3）：350-357.
[18]
Chera BS，Orlando C，Villaret DB，et al.Follicular dendritic cell sarcoma of the head and neck：case report and literature review[J].Laryngoscope，2008，118（9）：1607-1612.
[19]
Vaideeswar P，George SM，Kane SV，et al.Extranodal follicular dendritic cell sarcoma of the tonsil—case report of an epithelioid cell variant with osteoclastic giant cells[J].Pathol Res Pract，2009，205（2）：149-153.
[20]
Encabo RS，Mchugh J，Carrau RL，et al.Follicular dendritic cell sarcoma of the nasopharynx[J].Am J Otolaryngol，2008，29（4）：262-264.
[21]
Granados R，Aramburu JA，Rodríguez JM，et al.Cytopathology of a primary follicular dendritic cell sarcoma of the liver of the inflammatory pseudotumor-like type[J].Diagn Cytopathol，2008，36（1）：42-46.
Mao S，Dong J，Wang Y，et al.Follicular Dendritic Cell Sarcomas：CT and MRI Findings in 20 Patients[J].AJR Am J Roentgenol，2021，216（3）：835-843.
[27]
O′malley DP，Zuckerberg L，Smith LB，et al.The genetics of interdigitating dendritic cell sarcoma share some changes with Langerhans cell histiocytosis in select cases[J].Ann Diagn Pathol，2014，18（1）：18-20.
[28]
Perez-Ordonez B，Erlandson RA，Rosai J.Follicular dendritic cell tumor：report of 13 additional cases of a distinctive entity[J].Am J Surg Pathol，1996，20（8）：944-955.
[29]
Shia J，Chen W，Tang LH，et al.Extranodal follicular dendritic cell sarcoma:clinical，pathologic，and histogenetic characteristics of an underrecognized disease entity[J].Virchows Arch，2006，449（2）：148-158.
[30]
Bai LY，Kwang WK，Chiang IP，et al.Follicular dendritic cell tumor of the liver associated with Epstein-Barr virus[J].Jpn J Clin Oncol，2006，36（4）：249-253.
[31]
Padilla-Rodríguez AL，Bembassat M，Lazaro M，et al.Intraabdominal follicular dendritic cell sarcoma with marked pleomorphic features and aberrant expression of neuroendocrine markers：report of a case with immunohistochemical analysis[J].Appl Immunohistochem Mol Morphol，2007，15（3）：346-352.
[32]
Grogg KL，Lae ME，Kurtin PJ，et al.Clusterin expression distinguishes follicular dendritic cell tumors from other dendritic cell neoplasms：report of a novel follicular dendritic cell marker and clinicopathologic data on 12 additional follicular dendritic cell tumors and 6 additional interdigitating dendritic cell tumors[J].Am J Surg Pathol，2004，28（8）：988-998.
[33]
Chan JK，Fletcher CD，Nayler SJ，et al.Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized[J].Cancer，1997，79（2）：294-313.
京公网安备 11010502046607号